Raymond James & Associates’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-768
| Closed | -$95K | – | 4003 |
|
|
2021
Q1 | $95K | Buy |
768
+8
| +1% | +$990 | ﹤0.01% | 3722 |
|
|
2020
Q4 | $86K | Hold |
760
| – | – | ﹤0.01% | 3527 |
|
|
2020
Q3 | $91K | Hold |
760
| – | – | ﹤0.01% | 3344 |
|
|
2020
Q2 | $95K | Buy |
760
+490
| +181% | +$61.3K | ﹤0.01% | 3259 |
|
|
2020
Q1 | $52K | Buy |
+270
| New | +$52K | ﹤0.01% | 3277 |
|